Literature DB >> 29993659

Differentiating prostate cancer from benign prostatic hyperplasia using PSAD based on machine learning: Single-center retrospective study in China.

Yiyan Zhang, Qin Li, Yi Xin, Weiqi Lv.   

Abstract

The incidence of prostate cancer increases annually. Prostate cancer is an underreported and emerging problem in China. We conducted a cross-sectional study of 392 eligible patients from 710 men with prostate cancer or benign prostatic hyperplasia between 2000 and 2003. For total prostate-specific antigen, age, three diameters of prostate, prostate volume and prostate-specific antigen density seven indices, analysis of variance and t test were used to analyze the difference between the groups. A decision tree with pruning was established using the prostate-specific antigen density, age and transversal diameter of the prostate to screen the patient with prostate cancer. According to the established decision tree model, prostate-specific antigen density was the most important factor affecting the occurrence of prostate cancer. In elderly people over the age of 83 years, the transverse diameter of prostate cancer was smaller than that of benign prostatic hyperplasia, with prostate-specific antigen density less than . No additional index was introduced, and the detection rate of prostate cancer was 86.6 %.The specificity was enhanced to 78.1%.

Entities:  

Year:  2018        PMID: 29993659     DOI: 10.1109/TCBB.2018.2822675

Source DB:  PubMed          Journal:  IEEE/ACM Trans Comput Biol Bioinform        ISSN: 1545-5963            Impact factor:   3.710


  4 in total

1.  The roles of MRI-based prostate volume and associated zone-adjusted prostate-specific antigen concentrations in predicting prostate cancer and high-risk prostate cancer.

Authors:  Song Zheng; Shaoqin Jiang; Zhenlin Chen; Zhangcheng Huang; Wenzhen Shi; Bingqiao Liu; Yue Xu; Yinan Guo; Huijie Yang; Mengqiang Li
Journal:  PLoS One       Date:  2019-11-19       Impact factor: 3.240

Review 2.  Research and Application of Artificial Intelligence Based on Electronic Health Records of Patients With Cancer: Systematic Review.

Authors:  Xinyu Yang; Dongmei Mu; Hao Peng; Hua Li; Ying Wang; Ping Wang; Yue Wang; Siqi Han
Journal:  JMIR Med Inform       Date:  2022-04-20

3.  Radiomics-Based Machine Learning Models for Predicting P504s/P63 Immunohistochemical Expression: A Noninvasive Diagnostic Tool for Prostate Cancer.

Authors:  Yun-Fan Liu; Xin Shu; Xiao-Feng Qiao; Guang-Yong Ai; Li Liu; Jun Liao; Shuang Qian; Xiao-Jing He
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738

4.  Using clinical parameters to predict prostate cancer and reduce the unnecessary biopsy among patients with PSA in the gray zone.

Authors:  Junxiao Liu; Biao Dong; Wugong Qu; Jiange Wang; Yue Xu; Shuanbao Yu; Xuepei Zhang
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.